Alex Harocopos
Biographic Data
| ID | 6079103 |
|---|---|
| NAME | Alex Harocopos |
| GIVEN NAMES | Alex |
| FAMILY NAME | Harocopos |
| SIGNATURE | HAROCOPOS A |
| AFFILIATIONS | New York City Department of Health and Mental Hygiene |
| ORCID | 0000-0002-4650-762X |
| VERIFIED | Yes |
| TOTAL WORKS | 11 |
| TOTAL CITATIONS | 10 |
| AUTHOR COUNT | 11 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2003 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 2 |
New York City Neighborhood Wellness Survey: An expansive population-level behavioral health assessment of New York City residents, 2023
To identify and contextualize behavioral health needs among New York City residents ages 18 or older. The New York City Neighborhood Wellness survey was a population-based, cross-sectional survey conducted from May to September 2023. An address-based sampling approach was used to select households for participation, and one adult per household was asked to complete the survey. The survey primarily focused on mental health and substance use but al…
Expanded Naloxone Distribution by Opioid Overdose Prevention Programs to High-Need Populations and Neighborhoods in New York City
The Nation’s First Publicly Recognized Overdose Prevention Centers: Lessons Learned in New York City
In November of 2021, multiple factors converged to create a window of opportunity to open overdose prevention centers (OPCs) at two existing syringe service programs (SSPs) in New York City (NYC). Political will exists in NYC, particularly toward the end of the de Blasio administration's term, and the NYC Health Department worked to garner additional support from local and state elected officials given the dire need to address the overdose crisis…
Implementing a Methadone Delivery System in New York City in Response to Covid-19
Opioid agonist medication, including methadone, is considered the first-line treatment for opioid use disorder. Methadone, when taken daily, reduces the risk of fatal overdose; however, overdose risk increases following medication cessation. Amid an overdose epidemic accelerated by the proliferation of fentanyl, ensuring continuity of methadone treatment during the COVID-19 pandemic is a vital public health priority. (Am J Public Health. 2021;111…
Reformulation of oxycodone 80 mg to prevent misuse: A cohort study assessing the impact of a supply-side intervention
Substance Use Stigma, Primary Care, and the New York State Prescription Drug Monitoring Program
Prescription drug monitoring programs (PDMPs) are databases that track controlled substances at the provider, patient, and pharmacy levels. While these databases are widely available at the state level throughout the United States, several jurisdictions in recent years have mandated the use of these systems by health care providers. This study explores the implementation of mandatory PDMP technology in primary care practice and the effects on tre…
Circumstances and contexts of heroin initiation following non-medical opioid analgesic use in New York City
Initiation into prescription opioid misuse amongst young injection drug users
Patterns of Prescription Drug Misuse among Young Injection Drug Users
New injectors and the social context of injection initiation
Maintaining contact with drug users over an 18-month period
Maintaining contact with drug users over an 18-month period
Patterns of Prescription Drug Misuse among Young Injection Drug Users
The Nation’s First Publicly Recognized Overdose Prevention Centers: Lessons Learned in New York City
In November of 2021, multiple factors converged to create a window of opportunity to open overdose prevention centers (OPCs) at two existing syringe service programs (SSPs) in New York City (NYC). Political will exists in NYC, particularly toward the end of the de Blasio administration's term, and the NYC Health Department worked to garner additional support from local and state elected officials given the dire need to address the overdose crisis…
Maintaining contact with drug users over an 18-month period
New injectors and the social context of injection initiation
Initiation into prescription opioid misuse amongst young injection drug users
Patterns of Prescription Drug Misuse among Young Injection Drug Users
Circumstances and contexts of heroin initiation following non-medical opioid analgesic use in New York City
Substance Use Stigma, Primary Care, and the New York State Prescription Drug Monitoring Program
Prescription drug monitoring programs (PDMPs) are databases that track controlled substances at the provider, patient, and pharmacy levels. While these databases are widely available at the state level throughout the United States, several jurisdictions in recent years have mandated the use of these systems by health care providers. This study explores the implementation of mandatory PDMP technology in primary care practice and the effects on tre…
Reformulation of oxycodone 80 mg to prevent misuse: A cohort study assessing the impact of a supply-side intervention
Implementing a Methadone Delivery System in New York City in Response to Covid-19
Opioid agonist medication, including methadone, is considered the first-line treatment for opioid use disorder. Methadone, when taken daily, reduces the risk of fatal overdose; however, overdose risk increases following medication cessation. Amid an overdose epidemic accelerated by the proliferation of fentanyl, ensuring continuity of methadone treatment during the COVID-19 pandemic is a vital public health priority. (Am J Public Health. 2021;111…
The Nation’s First Publicly Recognized Overdose Prevention Centers: Lessons Learned in New York City
In November of 2021, multiple factors converged to create a window of opportunity to open overdose prevention centers (OPCs) at two existing syringe service programs (SSPs) in New York City (NYC). Political will exists in NYC, particularly toward the end of the de Blasio administration's term, and the NYC Health Department worked to garner additional support from local and state elected officials given the dire need to address the overdose crisis…
Expanded Naloxone Distribution by Opioid Overdose Prevention Programs to High-Need Populations and Neighborhoods in New York City
New York City Neighborhood Wellness Survey: An expansive population-level behavioral health assessment of New York City residents, 2023
To identify and contextualize behavioral health needs among New York City residents ages 18 or older. The New York City Neighborhood Wellness survey was a population-based, cross-sectional survey conducted from May to September 2023. An address-based sampling approach was used to select households for participation, and one adult per household was asked to complete the survey. The survey primarily focused on mental health and substance use but al…
Medicine (9 works) · Opioid Use Disorder Treatment (9 works) · Internal Medicine (6 works) · Opioid (6 works) · Psychiatry (6 works) · Substance Abuse Treatment and Outcomes (6 works) · HIV, Drug Use, Sexual Risk (5 works) · Drug (4 works) · Opioid use disorder (4 works) · Business (3 works)